Alkeus Pharmaceuticals Appoints Seemi Khan, M.D., Chief Medical Officer

Jan 23, 2024•over 1 year ago

Position

Chief Medical Officer

Company

Alkeus

Seemi Khan

CambridgeBiopharmaTherapeuticsPharmaceuticalBiotechnologyHealth Care

Description

Alkeus Pharmaceuticals, Inc. announces the appointment of Seemi Khan, M.D., M.P.H., M.B.A. as Chief Medical Officer.

Company Information

Company

Alkeus

Location

Cambridge, Massachusetts, United States

About

Alkeus Pharmaceuticals, Inc. is a private biopharmaceutical company with headquarters in Cambridge, Mass., backed by institutional investors led by Bain Capital Life Sciences. Founded in 2010, Alkeus is developing therapies for serious diseases of the eye with high unmet need. Alkeus’ breakthrough-designated lead candidate, gildeuretinol acetate (ALK-001), is currently being evaluated in clinical trials for the treatment of Stargardt disease and for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months